FOLFOX regimen trials for Colorectal cancer

All FOLFOX regimen trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying FOLFOX regimen for Colorectal cancer

• A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
  NCT05024097 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 3 locations
• Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
  NCT06475352 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 41 locations
• Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)
  NCT06991465 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study FOLFOX regimen for Colorectal cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.